Certified by Founder Lodge
Polaris Partners
United States - Boston, MA
INVESTOR
1 Disclosed Funding Rounds $30,000,000
18 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Exceptional entrepreneurs. Remarkable bonds. Extraordinary companies.
Since 1996, Polaris has been guided by the fundamental beliefs that people come first and true partnerships make all t
Company | Date | Round | Raised |
---|---|---|---|
FOLX Health | October, 17 ,2022 | Series B | $30,000,000 |
Neumora | October, 17 ,2022 | Series B | $112,000,000 |
CAMP4 Therapeutics | July, 20 ,2022 | Series B | $100,000,000 |
°Nomad Health | June, 27 ,2022 | Unknown | $105,000,000 |
Faro Health Inc. | February, 16 ,2023 | Unknown | $20,000,000 |
Volastra Therapeutics | March, 08 ,2023 | Series A | $60,000,000 |
Crossbow Therapeutics, Inc | July, 12 ,2023 | Series A | $80,000,000 |
Tausight | August, 16 ,2023 | Unknown | $6,000,000 |
Triveni Bio | October, 27 ,2023 | Series A | $92,000,000 |
Engine Biosciences | November, 01 ,2023 | Series A | $27,000,000 |
BeMe Health | November, 15 ,2023 | Unknown | $1,500,000 |
Seismic Therapeutic | December, 05 ,2023 | Series B | $121,000,000 |
Tome Biosciences | December, 14 ,2023 | Series B | $213,000,000 |
Cohere Health | February, 06 ,2024 | Unknown | $50,000,000 |
Matter Neuroscience | March, 01 ,2024 | Unknown | $26,000,000 |
Capstan Therapeutics | March, 21 ,2024 | Series B | $175,000,000 |
Livara Health | May, 03 ,2024 | Series B | $15,000,000 |
ByHeart | May, 14 ,2024 | Unknown | $95,000,000 |